SG11202001594TA - Iron complex compounds for therapeutic use - Google Patents
Iron complex compounds for therapeutic useInfo
- Publication number
- SG11202001594TA SG11202001594TA SG11202001594TA SG11202001594TA SG11202001594TA SG 11202001594T A SG11202001594T A SG 11202001594TA SG 11202001594T A SG11202001594T A SG 11202001594TA SG 11202001594T A SG11202001594T A SG 11202001594TA SG 11202001594T A SG11202001594T A SG 11202001594TA
- Authority
- SG
- Singapore
- Prior art keywords
- therapeutic use
- complex compounds
- iron complex
- iron
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
- C07F15/02—Iron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17190302 | 2017-09-11 | ||
PCT/EP2018/074293 WO2019048674A1 (en) | 2017-09-11 | 2018-09-10 | COMPLEX IRON COMPOUNDS FOR THERAPEUTIC USE |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202001594TA true SG11202001594TA (en) | 2020-03-30 |
Family
ID=59923237
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202001594TA SG11202001594TA (en) | 2017-09-11 | 2018-09-10 | Iron complex compounds for therapeutic use |
Country Status (12)
Country | Link |
---|---|
US (2) | US11111261B2 (es) |
EP (1) | EP3681539A1 (es) |
JP (2) | JP7426927B2 (es) |
KR (1) | KR20200044030A (es) |
CN (1) | CN111050802A (es) |
AU (1) | AU2018328052B2 (es) |
BR (1) | BR112020004357A2 (es) |
MA (1) | MA50229A (es) |
MX (3) | MX2020002527A (es) |
SG (1) | SG11202001594TA (es) |
WO (1) | WO2019048674A1 (es) |
ZA (1) | ZA202001283B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3681539A1 (en) * | 2017-09-11 | 2020-07-22 | Pharmacosmos Holding A/S | Iron complex compounds for therapeutic use |
SG11202107050RA (en) | 2019-01-10 | 2021-07-29 | Pharmacosmos Holding As | Treating iron deficiency in subjects at risk of cardiovascular adverse events and iron for the management of atrial fibrillation |
CN114286682A (zh) | 2019-02-09 | 2022-04-05 | 法码科思莫斯控股有限公司 | 治疗具有心血管不良事件风险的个体的铁缺乏以及用于治疗心房颤动的铁 |
LT3930686T (lt) | 2019-02-28 | 2023-10-10 | Renibus Therapeutics, Inc. | Naujos geležies kompozicijos ir jų gamybos bei naudojimo būdai |
WO2023012242A1 (en) | 2021-08-03 | 2023-02-09 | Pharmacosmos Holding A/S | Iron complex compounds for subcutaneous use in therapy of iron deficiency in companion animals |
CN117379387A (zh) * | 2022-01-13 | 2024-01-12 | 上海医药集团青岛国风药业股份有限公司 | 一种多糖铁胶囊内容组合物及方法 |
CN115177625A (zh) * | 2022-06-28 | 2022-10-14 | 金陵药业股份有限公司 | 一种羧基麦芽糖铁药用组合物及其制备方法 |
KR102623739B1 (ko) * | 2022-07-28 | 2024-01-11 | 주식회사 페라메드 | 시트르산과 철을 포함하는 착화합물 및 그를 포함하는 식품 조성물 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR607134A (fr) | 1924-12-03 | 1926-06-26 | Basf Ag | Procédé pour la production du fer carbonyle |
FR654013A (fr) * | 1928-05-09 | 1929-03-30 | Procédé de réglage de la carburation dans les moteurs à explosions et dispositifen permettant la réalisation | |
US2096855A (en) * | 1934-07-27 | 1937-10-26 | Innis Speiden & Co | Manufacture of ferric chloride |
US3639588A (en) | 1966-10-22 | 1972-02-01 | Fisons Pharmaceuticals Ltd | Pharmaceutical compositions containing ferric hydroxide complexed with dextran or dextrin heptonic acids |
US3906077A (en) | 1974-02-15 | 1975-09-16 | Kerr Mc Gee Chem Corp | Purification of ferric chloride |
US4056386A (en) | 1977-04-19 | 1977-11-01 | The United States Of America As Represented By The Secretary Of The Navy | Method for decomposing iron pentacarbonyl |
WO1999043408A1 (en) | 1998-02-25 | 1999-09-02 | Wadhawan Satish C | Solvent extraction of ferric chloride |
DK172860B1 (da) | 1998-03-25 | 1999-08-16 | Pharmacosmos Holding As | Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman |
DK173138B1 (da) | 1998-11-20 | 2000-02-07 | Pharmacosmos Holding As | Fremgangsmåde til fremstilling af en jerndextranforbindelse, jerndextranforbindelse fremstillet efter fremgangsmåden, farma |
US7871597B2 (en) | 1999-04-09 | 2011-01-18 | Amag Pharmaceuticals, Inc. | Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents |
DE10249552A1 (de) | 2002-10-23 | 2004-05-13 | Vifor (International) Ag | Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel |
US20060134227A1 (en) | 2004-12-22 | 2006-06-22 | Bortz Jonathan D | Compositions including iron |
ITMO20050056A1 (it) * | 2005-03-15 | 2006-09-16 | Biofer Spa | Processo per la preparazione di complessi del ferro trivalente con zuccheri mono-, di- e polisaccaridi. |
GB0702270D0 (en) * | 2007-02-06 | 2007-03-14 | Medical Res Council | Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation |
US8058462B2 (en) | 2007-02-06 | 2011-11-15 | Medical Research Council | Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation |
PL3156075T3 (pl) | 2009-03-25 | 2021-04-19 | Pharmacosmos Holding A/S | Oligosacharyd i sposób jego wytwarzania |
CN102065406B (zh) | 2009-11-12 | 2014-04-09 | 中兴通讯股份有限公司 | 一种本地呼叫本地交换的实现方法 |
LT3212182T (lt) | 2014-10-27 | 2019-10-10 | Pharmacosmos Holding A/S | Anemijos gydymas arba prevencija nėščiuose ne žmogaus žinduoliuose ir palikuonyse |
EP2913054A1 (en) | 2015-03-19 | 2015-09-02 | Pharmacosmos Holding A/s | Iron carbohydrate complex for treatment of restless leg syndrome (rls) |
WO2016181195A1 (en) * | 2015-05-08 | 2016-11-17 | Suven Life Sciences Limited | Improved process for water soluble iron carbohydrate complexes |
EP3310364B1 (en) | 2015-06-22 | 2021-09-15 | Pharmacosmos Holding A/s | Iron carbohydrate complex for treatment of iron deficiency of a fetus or an infant |
CN105095365A (zh) | 2015-06-26 | 2015-11-25 | 北京奇虎科技有限公司 | 一种信息流数据的处理方法和装置 |
KR102190963B1 (ko) * | 2016-05-20 | 2020-12-15 | 옵쉐스트바 스 아그라니첸너이아트?洲뵈?벤너스찌유 "빅-즈다로비예쥐 보트니흐" | 빈혈의 예방 및 치료를 위한 비타민을 함유하는 철 덱스트란 복합체의 즉시 사용가능한 주사 가능한 조성물 |
EP3681539A1 (en) * | 2017-09-11 | 2020-07-22 | Pharmacosmos Holding A/S | Iron complex compounds for therapeutic use |
-
2018
- 2018-09-10 EP EP18762868.0A patent/EP3681539A1/en active Pending
- 2018-09-10 SG SG11202001594TA patent/SG11202001594TA/en unknown
- 2018-09-10 JP JP2020513641A patent/JP7426927B2/ja active Active
- 2018-09-10 KR KR1020207007664A patent/KR20200044030A/ko not_active Application Discontinuation
- 2018-09-10 BR BR112020004357-5A patent/BR112020004357A2/pt unknown
- 2018-09-10 MX MX2020002527A patent/MX2020002527A/es unknown
- 2018-09-10 MA MA050229A patent/MA50229A/fr unknown
- 2018-09-10 CN CN201880058623.0A patent/CN111050802A/zh active Pending
- 2018-09-10 AU AU2018328052A patent/AU2018328052B2/en active Active
- 2018-09-10 WO PCT/EP2018/074293 patent/WO2019048674A1/en unknown
-
2019
- 2019-02-13 US US16/274,552 patent/US11111261B2/en active Active
-
2020
- 2020-02-28 ZA ZA2020/01283A patent/ZA202001283B/en unknown
- 2020-03-05 MX MX2023007810A patent/MX2023007810A/es unknown
- 2020-03-05 MX MX2023007809A patent/MX2023007809A/es unknown
-
2021
- 2021-08-18 US US17/405,438 patent/US20220041640A1/en not_active Abandoned
-
2023
- 2023-08-25 JP JP2023137244A patent/JP2023164477A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
MX2020002527A (es) | 2020-10-12 |
BR112020004357A2 (pt) | 2020-09-08 |
WO2019048674A1 (en) | 2019-03-14 |
JP2023164477A (ja) | 2023-11-10 |
AU2018328052A1 (en) | 2020-03-26 |
CN111050802A (zh) | 2020-04-21 |
ZA202001283B (en) | 2022-11-30 |
MA50229A (fr) | 2020-07-22 |
EP3681539A1 (en) | 2020-07-22 |
JP2020533300A (ja) | 2020-11-19 |
RU2020113257A3 (es) | 2022-04-25 |
US20190177353A1 (en) | 2019-06-13 |
US11111261B2 (en) | 2021-09-07 |
AU2018328052B2 (en) | 2024-02-29 |
US20220041640A1 (en) | 2022-02-10 |
MX2023007810A (es) | 2023-07-11 |
JP7426927B2 (ja) | 2024-02-02 |
KR20200044030A (ko) | 2020-04-28 |
MX2023007809A (es) | 2023-07-11 |
RU2020113257A (ru) | 2021-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201709456D0 (en) | Therapeutic agents | |
ZA202001283B (en) | Iron complex compounds for therapeutic use | |
GB201513540D0 (en) | Therapeutic agents | |
GB201509893D0 (en) | Therapeutic agents | |
GB201517263D0 (en) | Therapeutic agents | |
GB201810300D0 (en) | Compounds for new use | |
GB201603104D0 (en) | Therapeutic agents | |
HK1258727A1 (zh) | 治療性化合物 | |
IL282330A (en) | therapeutic compounds | |
GB201716942D0 (en) | Therapeutic compounds | |
GB201509885D0 (en) | Therapeutic agents | |
GB201509888D0 (en) | Therapeutic agents | |
GB201700553D0 (en) | Therapeutic agents | |
GB201617339D0 (en) | Therapeutic compounds | |
GB201616839D0 (en) | Therapeutic compounds | |
GB201513299D0 (en) | Therapeutic agents | |
GB201808150D0 (en) | Therapeutic compounds | |
GB201600376D0 (en) | Novel therapeutic agents | |
IL263821A (en) | Medicinal compounds | |
GB201517264D0 (en) | Therapeutic agents | |
GB201712393D0 (en) | Therapeutic compounds | |
GB201712392D0 (en) | Therapeutic compounds | |
GB201712388D0 (en) | Therapeutic compounds | |
GB201712390D0 (en) | Therapeutic compounds | |
GB201712394D0 (en) | Therapeutic compounds |